Injectable Pharma Packaging Market

The injectable pharma packaging market is projected to reach USD 98.8 billion by 2030 from USD 44.8 billion in 2025, at a CAGR of 17.5% from 2025 to 2030. The significant growth is driven by the rising demand for vaccines, insulin pens, and other injectable medicines, especially with the increasing prevalence of chronic and lifestyle diseases. Advances in biologic drugs are also playing a major role in expanding the injectable pharmaceutical packaging market. Additionally, the trend toward self-administration therapies and the adoption of smart packaging technologies, such as sensor-enabled packs and anti-counterfeiting measures, are further fueling the market for injectable pharma packaging.

• In 2024, Schott AG announced a joint venture with Serum Institute of India to boost pharmaceutical packaging capabilities. The collaboration strategy aims to strengthen Schott AG's presence in the pharmaceutical packaging industry. This will expand its portfolio by increasing manufacturing capacity and product offerings, further cementing its position in injectable pharma packaging and pharmaceutical solutions markets.
• In 2024, AptarGroup introduced a bio-based nasal spray pump aimed at enhancing sustainability. This product launch enables AptarGroup to promote its innovative sustainable packaging solutions in the pharmaceutical market, which the company has successfully developed.

Schott AG operates as a leading international company that dominates the market for pharmaceutical injectable packaging through its development of premium glass products and advanced packaging systems dedicated to injectable medications. The company supplies various products, including vials, ampoules, cartridges, and prefillable syringes, focusing on ready-to-use (RTU) formats that improve fill-finish processes and reduce contamination risks. The company specializes in developing innovative glass products, such as aluminosilicate-based solutions that boost chemical resistance and prevent delamination, thereby protecting delicate biological materials and vaccines. Its extensive global production capabilities and full integration into pharmaceutical distribution networks enable it to meet the rising demand for biologics, mRNA therapies, and secure, advanced packaging solutions.

To know about the assumptions considered for the study download the pdf brochure

Gerresheimer AG, based in Germany, has secured one of the largest market shares in the injectable pharma packaging industry. The company specializes in pharmaceutical packaging and has become an important player in glass and plastic packaging systems for the pharmaceutical sector. Known for delivering high-quality products with innovative features such as prefilled syringes and vials, it helps improve the quality of life for patients needing injectable medications. In recent years, Gerresheimer has expanded globally and gained recognition among pharmaceutical manufacturers through strategic partnerships and collaborations with healthcare providers, aiming to introduce advanced injectable packaging solutions and enhance their understanding of safe drug delivery systems.

Market Ranking

The key players in the injectable pharma packaging market have gained recognition for their comprehensive product offerings and ongoing technological innovations. Some major players include Schott AG (Germany), Gerresheimer AG (Germany), West Pharmaceutical Services (US), Stevanato Group (Italy), BD (Becton, Dickinson and Company) (US), SGD Pharma (France), Nipro Corporation (Japan), AptarGroup (US), Catalent, Inc. (US), and Datwyler Group (Switzerland). Schott and Gerresheimer AG are known for offering advanced packaging solutions, including easy-to-use models for pharmaceutical manufacturers and healthcare providers. West Pharmaceutical Services and AptarGroup maintain market leadership through their integrated injectable packaging systems, which ensure safe, precise containment and support rapid pharmaceutical manufacturing and clinical decision-making in both routine and specialized settings. Other notable companies like BD, Stevanato Group, and SGD Pharma are expanding the market with their innovative equipment aimed at improving workflow efficiency and healthcare quality. These key players have significantly contributed to increasing the reach of injectable pharma packaging solutions worldwide market.

Related Reports:

Injectable Pharma Packaging Market by Type (Prefilled Syringes, Vials, Ampoules, Cartridges), Packaging Type (Primary, Secondary), Application (Chronic Disease Management, Vaccines, Biologics, Insulin, Oncology), and Region-Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]